We are live on ! Find out more
Jane Street

Jane Street Portfolio holdings

AUM $777B
1-Year Est. Return 61.18%
 

Jane Street Group, founded in 2000 by Tim Reynolds, Rob Granieri, Marc Gerstein, and Michael Jenkins, is a New York City-based quantitative trading firm renowned for its technological prowess and collaborative problem-solving culture. Specializing in liquidity provision and market-making, it trades a vast array of financial products—including equities, bonds, options, and ETFs—across over 200 venues in 45 countries, handling trillions in securities annually. The firm, which employs over 2,600 people across offices in New York, London, Hong Kong, Amsterdam, Chicago, and Singapore, leverages advanced algorithms and a nearly 70-million-line OCaml codebase to dominate markets, notably ETFs, where it plays a critical role as an authorized participant. With net trading revenues exceeding $10 billion annually in recent years, including a record $10.6 billion in 2023, Jane Street has emerged as a secretive yet powerful force in global finance, outpacing traditional Wall Street giants like Goldman Sachs in trading profitability.

This Fund
S&P 500
This Quarter Est. Return
-1.27%
1 Year Est. Return
+61.18%
3 Year Est. Return
+147.64%
5 Year Est. Return
+157.48%
10 Year Est. Return
+673.77%
AUM
$283B
AUM Growth
+$27.4B
Cap. Flow
+$30.5B
Cap. Flow %
10.78%
Top 10 Hldgs %
36.77%
Holding
11,338
New
1,654
Increased
4,102
Reduced
3,903
Closed
1,507

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 2.35%
2 Technology 1.76%
3 Financials 1%
4 Communication Services 0.83%
5 Healthcare 0.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TGB
9501
CALL
Trekor Metals
TGB
$3.05B
$43K ﹤0.01%
22,600
-9,000
-28% -$16.2K
CLIM.WS
9502
DELISTED
Climate Real Impact Solutions II Acquisition Corporation Redeemable Warrants, each whole Warrant exercisable for one share of Class A Common Stock, each at an exercise price of $11.50 per share
CLIM.WS
$43K ﹤0.01%
40,610
+260
+0.6% +$304
GSQD.WS
9503
DELISTED
G Squared Ascend I Inc. Redeemable Warrants, each whole warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50
GSQD.WS
$43K ﹤0.01%
40,561
-63
-0.2% -$66
XPOA.WS
9504
DELISTED
DPCM Capital, Inc. Warrants, each whole warrant exercisable for one share of Class A Common Stock at
XPOA.WS
$43K ﹤0.01%
69,619
-1,125
-2% -$955
JAGX icon
9505
CALL
Jaguar Health
JAGX
$4.67M
0
SVM
9506
CALL
Silvercorp Metals
SVM
$2.53B
$42K ﹤0.01%
11,100
-34,000
-75% -$154K
NTBL
9507
DELISTED
Notable Labs, Ltd. Ordinary Shares
NTBL
$42K ﹤0.01%
+582
New +$45.4K
EMAN
9508
CALL
DELISTED
eMagin Corporation
EMAN
$42K ﹤0.01%
18,700
-13,400
-42% -$35.5K
PGRWW
9509
DELISTED
Progress Acquisition Corp. Warrant
PGRWW
$42K ﹤0.01%
75,433
+25
+0% +$16
ASAP
9510
CALL
DELISTED
Waitr Holdings Inc. Common Stock
ASAP
$42K ﹤0.01%
2,375
-2,105
-47% -$56.5K
TSIBW
9511
DELISTED
Tishman Speyer Innovation Corp. II Warrant
TSIBW
$42K ﹤0.01%
50,000
DSACW
9512
DELISTED
Duddell Street Acquisition Corp. Warrant
DSACW
$42K ﹤0.01%
62,789
-100
-0.2% -$78
ARDX icon
9513
PUT
Ardelyx
ARDX
$997M
$41K ﹤0.01%
31,400
-13,600
-30% -$36.3K
LPCN icon
9514
Lipocine
LPCN
$17.6M
$41K ﹤0.01%
+2,205
New +$48.7K
ATIP.WS
9515
DELISTED
ATI Physical Therapy, Inc. Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share
ATIP.WS
$41K ﹤0.01%
62,812
-479
-0.8% -$514
FSRDW
9516
DELISTED
Fast Radius, Inc. Warrants
FSRDW
$41K ﹤0.01%
50,000
-10
-0% -$10
MDH.WS
9517
DELISTED
MDH Acquisition Corp. Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share
MDH.WS
$41K ﹤0.01%
75,000
CKPT
9518
DELISTED
Checkpoint Therapeutics
CKPT
$40K ﹤0.01%
1,219
-1,452
-54% -$42.9K
SEEL
9519
PUT
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
$40K ﹤0.01%
4
-4
-50% -$34.4K
OCAXW
9520
DELISTED
OCA Acquisition Corp. Warrant
OCAXW
$40K ﹤0.01%
76,058
+308
+0.4% +$180
NRACW
9521
DELISTED
Northern Revival Acquisition Corporation Warrant
NRACW
$40K ﹤0.01%
58,300
UFAB
9522
DELISTED
Unique Fabricating, Inc.
UFAB
$40K ﹤0.01%
+12,100
New +$34.4K
BCLI
9523
PUT
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
$39K ﹤0.01%
793
-527
-40% -$27.7K
CIG.C icon
9524
CEMIG Ordinary Shares
CIG.C
$8.95B
$39K ﹤0.01%
21,076
-6,273
-23% -$11.2K
LVO icon
9525
LiveOne
LVO
$58.2M
$39K ﹤0.01%
1,308
-605
-32% -$20.9K

Similar funds

Jane Street's Q3 2021 Portfolio in Review

As of Q3 2021, Jane Street held 11,338 positions worth $283B, up 11% from $256B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Jane Street deployed $30.5B of net new capital in Q3 2021, opening 1,654 new positions and adding to 4,102 existing holdings. Its largest new stake was Vanguard FTSE Europe ETF: 5,046,582 shares worth $331M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 2.3% of assets, down from 2.5% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was iShares MBS ETF, an estimated $1.01B trimmed.

  • Jane Street's largest Q3 2021 buy was Vanguard FTSE Europe ETF: 5,046,582 shares worth $331M.
  • Jane Street added most to State Street SPDR S&P 500 ETF Trust in Q3 2021, an estimated $1.64B increase.
  • Jane Street's biggest Q3 2021 reduction was iShares MBS ETF, cutting an estimated $1.01B.
  • Jane Street fully exited Vanguard Tax-Exempt Bond Index Fund in Q3 2021, selling an estimated $338M.
  • Jane Street's ten largest holdings make up 37% of its $283B portfolio in Q3 2021.
  • Jane Street opened 1,654 new positions and closed 1,507 in Q3 2021.
  • Jane Street's portfolio value rose 11% quarter-over-quarter to $283B.

Based on Jane Street's 13F filing for Q3 2021, filed 16 Nov 2021.